Advanstar Communications The Leader in Conferences for the Pharmaceutical Industry

7th Annual Pharmaceutical/Biotech Accounting and Reporting Congress

Industry-Specific Best Practices, Updates on Changing FASB Guidelines and Strategies for Compliant Financial Reporting

March 14-15, 2011

Philadelphia, Pennsylvania

Order Now!

Now in its 7^th year, CBI’s Pharma/Biotech Accounting and Reporting Congress boasts the strongest agenda and speaker faculty to date – Over 40 speakers, choice of 3 in-depth workshops and 2 focused tracks of content! Accounting regulations are changing and healthcare reform has ushered in major changes to the life sciences industry. Do not miss this opportunity to hear the latest on technical accounting guidelines, auditing strategies and financial reporting best practices. Over 400 attendees are expected, so reserve your seat today!

Hear Expert Insights on:

SEC, FASB, IASB and PCAOB hot topics
IFRS adoption
Revenue recognition and collaboration accounting
Financial disclosures
Gross-to-net deductions and accruals
Capitalizing and accounting for R&D expenses
Valuation and impairment of intangible assets
Impact of the credit crisis and cash flow forecasting

For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.

Order Now!

David Levi

Share Links

Media Partners

Testimonials

Excellent topics and applicable focus. Converging accounting and finance issues, with industry developments was excellent!

Jim Mastakas

Chief Financial Officer, Sandoz

Annual opportunity to get the collective wisdom of the regulators, auditors and best in class consultants

Ray Minogue

Director of SEC Reporting, Par Pharmaceuticals

This conference lived up to its reputation. Great speakers, great content on hot topics makes this one of the best conferences I have attended.

Katie Kapadia

Vice President, Internal Audit, Elan Pharmaceuticals, Inc.

Probably the best conference for Pharma/Biotech accounting professionals out there. Top notch presenters and comprehensive review of most current finance/accounting hot topics.

Edward Stelmakh

Vice President Corporate Financial Planning and Analysis, Mylan

I was surprised at the level of detail and the precision of content that the presenters gave. I got a lot of information!

Kimberlee Gonzaga

Chief Financial Officer, Juvaris Biotherapeutics Inc.

I always get at least one key takeaway, which is worth significantly more than the cost to attend the conference!

Dave Lowrance

CFO, Cumberland Pharmaceuticals

This conference has developed into one of the most valuable conferences of the year for accounting and financial reporting professionals in our industry. Highly recommended!

Doug McCorkle

VP and Controller, Regeneron Pharmaceuticals

Even for a private company, this conference is very insightful with many practical takeaways.

Rob Burgess

CFO and VP of Administration, Merz Pharma

The Pharma/Biotech Accounting and Reporting Congress provides participants the opportunity to network with and learn from some of the top professionals in the industry. It is a unique conference, geared towards preparers.

Lewis Dulitz

Vice President, Accounting Policies and Research, Covidien

The conference is a great opportunity to network and stay current on relevant topics facing the industry.

Mark Cupo

Senior Director of Accounting and Reporting, sanofi-aventis

The conference provided an opportunity for companies to share best practices and ideas, what is of great value in the globalization of our business practices.

Duane Doucette

Senior Manager, Amgen

Very relevant and current information for any accounting personnel working in the Pharma industry.

Ira Duarte

Director of Accounting, Cornerstone Therapeutics

The material was current and pertinent to major issues facing the industry.

Michael Fipps

Chief Financial Officer, Osmotica Pharmaceutical Corp.

Excellent relevant revenue recognition information for all biotech finance and accounting professionals.

Deborah Schaub

Controller, Ceres

An excellent mix of technical accounting issues facing large and small pharma companies, as well as economic and political issues impacting the industry.

Bob Hauer

VP and Controller, Wyeth Pharmaceuticals

The seminar is a great review of hot issues the industry is facing.

Chris Nicholas

Controller, Shire

Engaged speakers and relevant topics puts this conference on my need to attend list each year!

Richard Morris

Controller and Chief Accounting Officer, ViroPharma Inc.

Speakers were very good and provided useful examples to help understanding.

Christopher Giolli

AVP Finance and CFO, Wyeth

Not only timely information and great networking each year, but after five years the conference is attracting very influential speakers.

Debra Mohollen

Assistant Controller, Viro Pharma

This conference continues to be particularly beneficial to financial reporting professionals in the pharma/biotech industry. Highly recommended!

Douglas McCorkle

Vice President and Controller, Regeneron Pharmaceuticals

This conference is full of information that adds value to your career and your ability to add value to your company.

Ray Minogue

Director of SEC Reporting, Par Pharmaceuticals

One of the few conferences where you get real insight into the pharma industry and its stakeholders.

Brian Staalkjaer

Corporate Accounting Manager, Novo Nordisk

A great opportunity to gain knowledge on issues being faced by the pharmaceutical industry today, as well as networking with the individuals who deal with them.

Keith Ruck

Corporate Controller, Lannett

The conference was an excellent vehicle for better understanding of accounting changes, the future of accounting changes and understanding where my peer group stands on similar issues.

Nancy Stempin

Director of Finance, Novartis

Great Content. Great Speakers. Relevant Industry Topics.

Lauren Riker

Senior Director of Financial Reporting, Ikana

Great exposure to issues in accounting.

Tint Tint Yap

Director of Accounting, Bayer Healthcare

Reproduction in whole or in part is prohibited. Please send any technical comments or questions to our webmaster.